Table 1. Mouse models used in this study.
Mouse models | Genotypes | Background | References |
---|---|---|---|
K14 HPV-8* | K14 HPV-8 | C57/Bl6 | [16] |
K14 HPV-8/K14 N17Rac1 | K14 HPV-8; K14 N17Rac1 | C57/Bl6 | [16, 17] |
K14 HPV-8 | K14 HPV-8 | FVB/N | [16] |
K14 L61Rac1 | K14 L61Rac1 | FVB/N | [19] |
K14 HPV-8/ K14 L61Rac1 | K14 HPV-8; K14 L61Rac1 | FVB/N | [16, 19] |
K14 HPV-8/ Rac1-EKO | K14 HPV-8; K14 Cre; Rac1 fl/fl | FVB/N | [16–18] |
K14 HPV-8/ Rac1-EKOhet | K14 HPV-8; K14 Cre; Rac1 fl/+ | FVB/N | [16–18] |
K14 HPV-8 mice in C57/Bl6 background were used as controls with K14 HPV-8/K14 N17Rac1 mice in C57/Bl6 background. All other mice were used in FVB/N background.
K14 HPV-8: complete early region of HPV-8 expressed under the control of K14 promoter. K14 N17Rac1: Dominant negative mutant of Rac1 expressed under the control of K14 promoter. K14 L61Rac1: Constitutively active mutant of Rac1 expressed under the control of K14 promoter. Rac1-EKO and Rac1-EKOhet: Cre recombinase expressed under the control of K14 promoter with two floxed alleles of Rac1 (Rac1-EKO) or one floxed allele and one wild type allele (Rac1-EKOhet).